Single agent chemotherapy in the management of ovarian carcinoma
- 1 January 1985
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinomaEuropean Journal of Cancer and Clinical Oncology, 1982
- Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaCancer, 1978
- Pulmonary histopathologic changes associated with melphalan therapyCancer, 1978
- Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agentsGynecologic Oncology, 1978
- Acute leukemia after chemotherapy (melphalan)Cancer, 1978
- Selective Localization of 4-(9-Acridinylamino)-methanesulfon-m-anisididein B 16 MelanomaPharmacology, 1978
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977
- Phase II study of porfiromycin vs mitomycin‐c utilizing acute intermittent schedulesMedical and Pediatric Oncology, 1976
- Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinomaEuropean Journal of Cancer (1965), 1975
- Treatment of cancer with weekly intravenous 5-fluorouracil.Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG)Cancer, 1971